ESR1 and breast cancer: Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and is the most aggressive type accounting for 15–20% of all breast cancer cases2 with poor prognosis3.